title: Rapid simultaneous determination of telmisartan, amlodipine besylate and hydrochlorothiazide in a combined poly pill dosage form by stability-indicating ultra performance liquid chromatography.
abstract: A simple, precise and rapid stability-indicating ultra-performance liquid chromatography (UPLC) method is developed for the simultaneous quantitative determination of Telmisartan, Amlodipine besylate and Hydrochlorothiazide from their innovative poly pill combination drug product in the presence of degradation products. It involves a 100 mm x 2.1 mm, 1.7 μm C-18 column. The separation is achieved on a simple gradient method. The mobile phase A contains a mixture of sodium perchlorate buffer pH 3.2 (0.053M): acetonitrile in the ratio 90:10, v/v, and mobile B contains a mixture of sodium perchlorate buffer pH 3.2 (0.053M): acetonitrile in the ratio 20:80, v/v. The flow rate is 0.6 mL min(-1) and the column temperature is maintained at 55°C.The gradient program (T/%B) is set as 0/5, 1.2/5, 1.6/40, 4/40, 4.1/5 and 4.5/5. The detector wavelength is 271 nm for Hydrochlorothiazide and Telmisartan and 237 nm for Amlodipine. The retention times of Telmisartan, Amlodipine, and Hydrochlorothiazide are 3.6 minutes, 3.2 minutes and 0.9 minutes; respectively. The total runtime for the separation of the three active compounds and their degradation products is 4.5 minutes. The described method is validated with respect to system suitability, specificity, linearity, precision and accuracy. The precision of the assay method is evaluated by carrying out six independent assays of T, A and H (0.032 mg mL(-1) of T, 0.004 mg mL(-1) of A, 0.01 mg mL(-1) of H). The accuracy of the method is evaluated in triplicate at three concentration levels, i.e. 50%, 100% and 150% of target test concentration (0.64 mg mL(-1) of T, 0.08 mg mL(-1) of A, 0.2 mg mL(-1) of H). The described method is linear over the range, 16 to 48 μg mL(-1) for T, 2 to 6 μg mL(-1)A and 5 to 15 μg mL(-1) for H. The method is fast and suitable for high-throughput analysis allowing the analysis of about 250 samples per working day.
authors: Analytical Research and Development, Integrated Product Development, Dr. Reddy's Laboratories Ltd., Bachupally, Hyderabad-500 072, India. nalwadesu@drreddys.com
authors: Santaji
authors: S
authors: Nalwade
authors: Vangala
authors: V
authors: Ranga Reddy
authors: Dantu
authors: D
authors: Durga Rao
authors: Inabathina
authors: I
authors: Koteswara Rao
references: J Pharm Biomed Anal. 2002 Jun 15;28(6):1011-40
references: 12049968
references: J Pharm Biomed Anal. 2001 Feb;24(4):603-11
references: 11272317
references: J Pharm Biomed Anal. 2008 Dec 1;48(4):1225-9
references: 18838240
references: J Pharm Biomed Anal. 2006 Jun 7;41(3):1037-40
references: 16495029
references: J Pharm Biomed Anal. 2006 Jan 23;40(1):151-6
references: 16111848
references: J Pharm Biomed Anal. 2008 Feb 13;46(3):583-6
references: 18155869
references: J Pharm Biomed Anal. 2006 Feb 24;40(3):605-13
references: 16324814
references: J Pharm Biomed Anal. 2005 Sep 1;39(1-2):147-55
references: 15939562
references: J Pharm Biomed Anal. 2003 Feb 26;31(2):329-39
references: 12609672
references: J Pharm Biomed Anal. 2009 Sep 8;50(2):194-9
references: 19446420
references: Pharm Methods. 2010 Oct;1(1):39-43
references: 23781414